Bone Development Articles & Analysis
23 news found
Testing your bone density may not be a usual task on your priority list, but May serves as National Osteoporosis Month and can serve as a friendly reminder to check your bone density. ...
The company intends to pursue multiple applications in the distal extremity, trauma, sports, reconstruction, pediatrics and spine segments. About OSSIOfiber Intelligent Bone Regeneration Technology Designed for rapid bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a first-of-its-kind implant ...
This is the third FDA clearance for the company’s OSSIOfiber® Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind. ...
This represents an important starting point for KLISBio and paves the way to the development of SILKBridge® future clinical strategy” said Antonio Alessandrino, CTO and Founder of KLISBio. ...
ByKLISBio
KLISBio is targeting a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained drug release is needed. ...
ByKLISBio
“TheraCell has excelled in developing advanced bone integrating, anchoring, and bridging technologies for spinal repair for over a decade including their award winning TheraFuze DBF® Fiber Anchor™ and TheraFuze DBF® Fiber ...
Monk will work closely with C-level management, research scientists, manufacturing, and our Quality and Regulatory team and services providers to mature NuShores’ bone and tissue regeneration product development efforts. NuShores is currently working on several new medical devices based on our pipeline of UALR licenses and internally ...
KLISBio is focused on healing and regenerating human body tissues by developing innovative solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, ...
ByKLISBio
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® FLEX SP EXTREMITIES, Synthetic Bioactive Bone Graft. ...
“KLISBio has developed a versatile technology platform with the aim to rethink the way tissue engineering is performed, offering new solutions and leveraging pure silk fibroin as biocompatible ...
ByKLISBio
About KLISBio: KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release. ...
ByKLISBio
“KLISBio is focused on developing innovative solutions to tackle prominent unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, tendon tears and situations where a sustained ...
ByKLISBio
Tell your healthcare provider right away if you develop side pain or fever during treatment with JELMYTO. Bone marrow problems. JELMYTO can affect your bone marrow and can cause a decrease in your white blood cell, red blood cell, and platelet counts. ...
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. ...
This tissue engineered technology is based on pure silk fibroin that merges a deep-rooted cultural tradition and know-how with the most advanced technologies creating a highly purified material needed for biomedical applications, without the need for chemical cross-linking reactions that alter the protein. KLISBio is focused on developing innovative solutions that solve ...
ByKLISBio
KLISBio is focused on healing and regenerating human body tissues by developing innovative solutions that solve prominent, unmet clinical needs through a silk-based multidisciplinary technology platform able to generate products and solutions for a variety of clinical indications, such as peripheral nerve injuries, peripheral vascular diseases, bone defects, ...
ByKLISBio
The company is also working on silk technologies focused on vascular grafting, rotator cuff repair, bone grafting and drug release which they plan to launch between now and 2028. ...
ByKLISBio
The technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone Zetagen Therapeutics is developing the therapy for patients living with metastatic bone lesions and other osteologic conditions The Company is targeting its first human clinical trial for metastatic bone ...
The rebranding contributes to the strengthening of the Grenoble-based company's position as a rising player in surgical robotics. eCential Robotics, which has experienced strong growth since the commercial launch of its platform in December 2017, has secured equity, quasi-equity and debt financing, totaling close to 100 million euros to support its industrial and commercial ...
Little Rock, AR – NuShores Biosciences LLC has won a 3-year, $2.8M contract from the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium associated with the U.S. Army Medical Research and Development Command. The contract will enable NuShores to develop intelligent automated production of its NuCress™ ...